Suicide prevention is a crucial component of global mental health strategies. Historical crises have shown that societal stress and anxiety can lead to increased suicide rates. Addressing these challenges requires early intervention and continuous support, both of which are core elements of the BIC program.

The BIC program was initially tested through a multicentre randomised controlled trial (RCT) under the WHO SUPRE-MISS initiative. The study included participants from five countries—Brazil, India, Iran, Sri Lanka, and China—who had attempted suicide and sought emergency care.

• Brief Intervention: Educating individuals on suicide risk factors, protective measures, and treatment adherence.
• Long-term Follow-up: Continuous contact for up to 18 months, independent of psychiatric treatment.
• Structured Support: Intensive follow-ups at 1, 2, 4, 8, and 12 weeks, with gradually reduced frequency over 12 months.
• Proven Effectiveness: The trial showed a statistically significant reduction in suicide rates among participants receiving the intervention.

The BIC project is now being expanded globally to reach more individuals at risk. Mental health professionals and researchers are encouraged to adopt and evaluate the methodology in their clinical practice while acknowledging the WPA.

This initiative is not only about intervention but also about understanding barriers to implementation and ensuring cultural adaptability across different healthcare systems. The goal is to build a strong evidence base for national mental health policies and practices.